Early Inflammatory Biomarkers as Predictive Factors for Freedom from Infection after Colorectal Cancer Surgery: A Prospective Cohort Study by Goulart, André et al.
Early Inﬂammatory Biomarkers as Predictive Factors
for Freedom from Infection after Colorectal Cancer Surgery:
A Prospective Cohort Study
Andre´ Goulart,1,2 Carla Ferreira,2 Alexandra Estrada,3 Fernanda Nogueira,1 Sandra Martins,1,2
Anto´nio Mesquita-Rodrigues,1 Nuno Sousa,2 and Pedro Lea˜o1,2
Abstract
Purpose: Different biomarkers are useful in diagnosing infections. The aim of this work was to clarify the
relation between different inﬂammatory biomarkers (white blood cell [WBC] count, C-reactive protein [CRP],
procalcitonin [PCT], and C-reactive protein-to-albumin ratio [CAR]) and early infectious complications after
colorectal surgery.
Methods: This prospective single-center cohort study included 130 patients undergoing elective colorectal surgery.
TheWBCcount, CRP, and PCTweremeasured at post-operative day one (POD1) and POD3 and albumin on POD3.
Results: Patients with surgical site infections (SSI) exhibited signiﬁcantly higher CRP concentrations on POD1
and CRP and CAR on POD3 than did patients without SSI. According to receiver operating characteristic
analysis, the CRP concentration on POD1 and the CRP and CAR on POD3 showed the highest area under the
curve (AUC) for predicting SSI (AUC 0.639, 0.736, and 0.729, respectively). Multivariable logistic regression
analysis showed that CRP on POD1 and CRP and CAR on POD3 were independent predictors of SSI (odds ratio
7.355, 7.605, and 8.337, respectively).
Conclusions: The CRP concentration on PO1 and CRP and CAR on POD3 can positively identify patients at
low risk of SSI. They can be used as a prognostic tool to predict an uneventful post-operative period and
therefore have been incorporate into our discharge criteria after elective colorectal resection, improving clinical
decision-making.
Keywords: colorectal cancer; C-reactive protein; C-reactive protein-to-albumin ratio; surgical site infection
Recent advances in colorectal cancer surgery techniqueand peri-operative care had little impact in the overall
complication rate, which remains at about 30% [1]. In-
fectious complications remain a major clinical problem in
colorectal surgery, contributing to signiﬁcant post-operative
morbidity, prolonged hospital stay, additional cost, and
more deaths [2].
Despite the importance of early diagnosis of infections in
order to initiate the treatment as soon as possible, their diagnosis
usually is difﬁcult, delaying their resolution. Therefore, there is
a clear necessity for early sensitive and speciﬁc markers for
post-operative infections [2]. Several biomarkers of infection,
namely white blood cell (WBC) count and C-reactive protein
(CRP) and procalcitonin (PCT) concentrations, have proved
useful in the diagnosis of infection in different clinical settings
as well as in the assessment of its response to antibiotic therapy
[2–4]. Also, a low serum albumin concentration is associated
with post-operative complications [5, 6].
In the presence of inﬂammation, the liver synthesizes an
acute-phase reactant called CRP, which can be found in the
blood as a result of stimulation by interleukin-6 and tumor
necrosis factor-alfa [7]. It probably plays an important role in
innate immunity by assisting complement binding to foreign
and damaged cells and enhancing phagocytosis by macro-
phages, thus acting as an early defense against infection [8].
Production of CRP is part of a nonspeciﬁc acute-phase re-
sponse to most forms of infection, tissue damage, inﬂam-
mation, and malignant disease [7].
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Also, PCT is the inactive 116-amino-acid pro-peptide of
the hormone calcitonin. Patients with sepsis or less severe
bacterial and fungal infectiond show an increase in the con-
centration of PCT [9]. The concentration is a valuable marker
for inﬂammation, and the central role of PCT as an early and
reliable diagnostic and prognostic tool in contexts such as
infection and sepsis and both infectious and non-infectious
systemic inﬂammatory response syndrome (SIRS) has been
demonstrated [9].
An early decrease in the post-operative serum albumin
concentration is associated with adverse clinical outcomes
and results from surgical insult [10]. The greater capillary
leakage of albumin is one of the characteristics of SIRS,
leading to a low plasma albumin concentration in patients
undergoing major abdominal surgery [11].
The WBC count, CRP, and PCT have been studied by
several authors as early predictors of infectious complications.
However, there still is no consensus regarding the diagnostic
accuracy of each one for early detection of complications in
patients undergoing colorectal surgery [3,9,12,13]. However,
the CRP-to-albumin ratio (CAR) has received almost no
studies to determine its diagnostic accuracy for post-operative
complications in patients undergoing colorectal surgery [5].
The aim of this work was to clarify the relation between dif-
ferent inﬂammatory biomarkers (WBC, CRP, PCT, and CAR)
and early infectious complications of colorectal surgery.
Patients and Methods
Study design and selection of participants
This study was approved by the local ethics committee. It
was a prospective single-center cohort study that included all
patients with colorectal adenocarcinoma who underwent
elective surgery in our institution from August 2015 to Au-
gust 2016. Exclusion criteria were evidence of metastasis
before or at surgery, synchronous tumors, and absence of
colorectal adenocarcinoma in the surgical specimen.
Data collection
The range of data collected included baseline characteristics
such as age and sex, co-morbidities such as arterial hyper-
tension and dyslipidemia, and type of surgery (laparoscopy vs
laparotomy). The laboratory data collected were WBC count,
CRP (mg/L), and PCT (ng/mL) on post-operative day (POD) 1
and POD3 and albumin (g/dL) on POD 3.
All post-operative infectious complications were recorded
according to the Surgical Site Infection (SSIs) Guidelines and
were classiﬁed as superﬁcial incisional (involves only skin
and subcutaneous tissue of the incision), deep incisional
(involves deep soft tissues of the incision such as fascial and
muscle layers), and organ/space (involves any part of the
body deeper than the fascial/muscle layers that is opened or
manipulated during the operative procedure). In this study,
SSIs were all conﬁrmed by the same attending physician. The
follow-up period was 30 days after surgery.
Data analysis
Statistical analysis was performed using the 2016 Statis-
tical Package for the Social Science Program (SPSS) version
24 (IBM Corporation, Armonk, NY). Descriptive statistics
are presented as frequencies (n) and percentages (%) for
categorical variables and as means (M) and standard devia-
tions (SD) for quantitative variables, after checking to see if
the asymmetry coefﬁcient fell inside the [-2; 2] interval.
Univariable analysis between laboratory data and SSI were
performed with the independent-sample t-test.
Receiving operator characteristic (ROC) curves were built
in order to assess the sensitivity and speciﬁcity of the bio-
markers WBC count, CRP, and PCT one and three days after
surgery. The CAR was calculated three days after surgery.
Precision was calculated as the area under the curve (AUC)
(null hypothesis—H0—was AUC = 0.5). We also calculated
the positive and negative predictive values for the signiﬁcant
early biomarkers.
Finally, adjusted odds ratios (ORs) were determined for the
signiﬁcant early biomarkers using adjusted unconditional lo-
gistic regression. The confounders tested were sex, age, arterial
hypertension, type II diabetes mellitus, dyslipidemia, and sur-
gical approach. Signiﬁcant results were considered as p< 0.05.
This work has been reported in line with the STROCSS
criteria [14].
Results
Study population and baseline characteristics
From August 2015 to August 2016, a total of 138 patients
were enrolled, and eight patients were excluded, four because
of high-grade dysplasia and one each for serrated adenoma,
lipoma, metastasis at surgery, and adenocarcinoma of the
appendix. There were 81 men (62.3%) and 49 women with a
mean age of 67.83 years (SD 13.07) and a median age of 68.5
Table 1. Patient, Tumor Characteristics,
and Treatment Complications
Variable N (%)
Arterial hypertension 74 (56.9)
Type II diabetes mellitus 35 (26.9)
Dyslipidemia 53 (40.8)
Location of the tumor
Colon 97 (74.6)
Rectum 33 (25.4)
If rectum, neoadjuvant treatment 14 (42.4)
Surgical approach
Laparoscopy 59 (45.4)
Converted laparoscopy 8 ( 6.2)
Laparotomy 63 (48.5)
30-day complication grade (Clavien Dindo)
None 95 (73.1)
I 8 ( 6.2)
II 13 (10.0)
IIIa 3 ( 2.3)
IIIb 7 ( 5.4)
IVa 1 ( 0.8)
IVb 2 ( 1.5)
V 1 ( 0.8)
Anastomotic leaka 10 ( 8.3)
Dukes stage
Not classiﬁable (Tis or yT0) 6 ( 4.5)
A 41 (31.5)
B 43 (33.1)
C 40 (30.8)
aAnastomotic leak occurred in 10 of 121 patients with anastomoses.
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years (range 34–91 years). The rest of the baseline charac-
teristics, surgery and treatment performed, and pathologic
characteristics of the tumor are summarized in Table 1. There
were 26 patients (20.0%) who had detectable SSIs. Of these,
12 patients (9.2% of the total series) had superﬁcial incisional
SSI, 1 (0.8%) had deep incisional SSI, and 13 (10.0%) had
organ/space SSI.
Predictive clinical features
To assess the utility of clinical features for the early as-
sessment of SSIs, analysis of the WBC count, CRP concen-
tration (mg/L), and PCT concentration (ng/mL) was made on
PODs 1 and 3, whereas the concentration of albumin (g/dL)
was measured only on POD 3 (Table 2). On POD1, patients
with SSI exhibited signiﬁcantly higher CRP concentrations
than did those without SSI (p < 0.05). On POD3, patients with
SSI exhibited higher CRP concentrations and CAR values
than did those in the non-SSI group (p< 0.05). There were no
statistically signiﬁcant differences between the two groups in
WBC count or PCT on PODs 1 and 3. The surgical approach
(laparoscopy vs. laparotomy) was associated with a statistical
difference in the development of SSI (p= 0.035) and ex-
hibited differences in the laboratory values of the inﬂam-
matory markers (Table 3).
To compare each marker and to determine the optimum
cut-off for SSI diagnosis, ROC analysis was performed. On
POD1, CRP was the most reliable predictor of SSI (cut-off
value 73mg/L; AUC 0.639). On POD3, the CAR was a sig-
niﬁcant predictor of SSI (cut-off value 43; AUC 0.736) as
was CRP (cut-off value 123mg/L; AUC 0.729) (Fig. 1).
The optimum cut-off and the corresponding sensitivity,
speciﬁcity, and positive and negative predictive values are
summarized in Table 4.
Risk and predictive factors for SSI after colorectal
cancer surgery
Adjusted logistic regressions showed signiﬁcant results for
CRP on POD1 and CRP and CAR on POD3 for the risk of
infection. For CRP on POD1, our proposed cut-off value was
associated with a risk 7.355 times higher for patients with SSI
(odds ratio [OR] 7.355; 95% conﬁdence interval [CI] 12.076–
26.066; p = 0.002). For CRP on POD3, our proposed cut-off
was associated with a risk 7.605 times higher for patients with
SSI (OR 7.605; 95% CI 2.313–25.007; p = 0.001). For CAR,
our proposed cut-off showed a risk 8.337 times higher for
patients with SSI (OR 8.337; 95% CI 2.202–20.168;
p = 0.001) (Table 5).
Discussion
After colorectal cancer surgery, the most signiﬁcant source
of morbidity and delay of discharge is infectious complica-
tions. Through the use of newer biochemical markers (CPR
and PCT), it may be possible to predict accurately a group of
patients at higher risk of poor outcome because of infections
[8] and, at the same time, help to identify patients for safe
early discharge [7].
For many surgeons, the early identiﬁcation of SSI is still a
challenge. In the period after elective colorectal surgery, SSI
can lead to prolonged hospital stays, increased morbidity and
Table 2. Statistical Results Comparing Laboratory Variables with Surgical Site Infection
Percent of patients
evaluated SSI (mean) No SSI (mean) p
Post-operative day 1
White blood cells (cells/mm3) 100 10.6 10.7 0.823
C-reactive protein (mg/L) 100 101.7 77.5 0.024
Procalcitonin (ng/mL) 93 2.2 1.6 0.545
Post-operative day 3
White blood cells (cells/mm3) 96 9.3 9.2 0.983
C-reactive protein (mg/L) 96 177.9 106.9 0.000
Procalcitonin (ng/mL) 96 2.6 1.7 0.407
Albumin (g/dL) 96 2.6 2.9 0.063
C-reactive protein-to-albumin ratio 96 74.8 38.8 0.000
Table 3. Statistical Results Comparing Laboratory Variables with Surgical Approach
Percent of patients
evaluated
Laparotomy
(mean)
Laparoscopy
(mean) p
Post-operative day 1
White blood cells (cells/mm3) 100 10.9 10.4 0.327
C-reactive protein (mg/L) 100 102.5 56.7 0.000
Procalcitonin (ng/mL) 93 3.0 0.2 0.001
Post-operative day 3
White blood cells (cells/mm3) 96 8.7 9.9 0.489
C-reactive protein (mg/L) 96 145.7 94.2 0.002
Procalcitonin (ng/mL) 96 2.9 0.6 0.022
Albumin (g/dL) 96 2.6 3.1 0.000
C-reactive protein-to-albumin ratio 96 59.2 31.2 0.000
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mortality rates, and higher medical costs [5]. Despite the
combined evaluation of clinical, laboratory, and radiologic
ﬁndings, early diagnosis of SSI cannot be made reliably by
any known individual feature or even by experienced clinical
judgment [9].
When most studies try to ﬁnd a predictive factor for in-
fection, few have attempted to identify predictors of an un-
eventful post-operative course in terms of infection. But such
information can be valuable in developing algorithms for
discharge. This study demonstrated an increase in CRP on
POD1 and in CRP and CAR on POD3 with signiﬁcant dif-
ferences between patients with and without complications.
The ROC curve analysis showed that the CRP concentration
on POD1 and CRP and CAR on POD3 predict the develop-
ment of post-operative infectious complications. In adjusted
logistic regressions, both CRP on POD1 and CRP and CAR
on POD3 were identiﬁed as independent predictors of SSI.
Our study shows that using a cut-off value for CRP of
73mg/L on POD1 may have sensitivity and speciﬁcity ade-
quate to be used for clinical decision making, but the most
important ﬁnding is that, in our population, CRP £73mg/L on
POD1 predicted an uncomplicated course in 91.5% of pa-
tients. Although most studies agree that CRP on PO1 is
inﬂuenced by surgical insult [2,8,15] and its post-operative
peak occurs at 48 hours after surgery [2], the lack of increase
in the CRP concentration on the ﬁrst post-operative day is a
predictor of a complication-free post-operative period.
At POD3, most studies suggest that CRP is a predictor of
infectious complications [2, 7,15]. In our study, as on POD1,
CRP at a cut-off 123mg/L on POD3 had a high negative
predictive value (91.2%).
Similarly, we studied CAR, which is based on circulating
concentrations of two acute-phase proteins, CRP and albu-
min, which are associated with inﬂammation caused by sur-
gical insult. In this way, we concluded that almost all patients
with CAR £43 on POD3 will not develop an SSI (negative
predictive value 90.7%).
The research on CAR is still in development. Ge et al. [5]
found that patients with CAR >2.2 on POD3 should be
monitored intensively for early detection of post-operative
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FIG. 1. Receiver operating characteristics curves of C-reactive protein (CRP) on POD1 and CRP and C-reactive protein-
to-albumin ratio (CAR) on POD3.
Table 4. Sensitivity, Speciﬁcity, Negative Predictive
Value (NPV), Positive Predictive Value (PPV),
and Optimum Cut-Off of Each Marker Based
on ROC Curve
Cut-off
Sensitivity
(%)
Speciﬁcity
(%)
PPV
(%)
NPV
(%)
CRP POD1 73 81.8 55.1 34.0 91.5
CRP POD3 123 77.3 70.3 43.6 91.2
CAR POD3 43 77.3 66.2 40.5 90.7
CAR =C-reactive protein-to-albumin ratio; CRP =C-reactive
protein; POD= post-operative day.
Table 5. Adjusted Logistic Regressions (Adjusted
for Confounders Sex, Age, Arterial Hypertension,
Type II Diabetes Mellitus, Dyslipidemia,
and Surgical Approach)
Adjusted OR 95% CI p
CRP POD1 7.355 2.076–26.066 0.002
CRP POD3 7.605 2.313–25.007 0.001
CAR POD3 8.337 2.202–20.168 0.001
CI = conﬁdence interval; OR= odds ratio; POD = post-operative
day.
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complications. Shibutani et al. [16] found pre-operative CAR
to be a useful prognostic marker in patients with colorectal
cancer undergoing potentially curative surgery. In patients
with sepsis, Ranzani et al. [17] reported that residual in-
ﬂammation at ICU discharge, as assessed by CAR, was an
independent risk factor for a poor outcome.
ElevatedWBC count is a nonspeciﬁc inﬂammatory marker
and one of the SIRS criteria. Therefore, it is not surprising
that the count had a poor diagnostic performance for infection
in patients in the intensive care unit and post-operatively [15].
However, some studies have reported a late increase in WBC
counts in patients with infectious complications of colorectal
surgery, correlating with the clinical diagnosis of complica-
tions [15]. We could have missed this late increase, as we
assessed inﬂammatory markers only on PODs 1 and 3. Fur-
thermore, in our study, PCT failed as a predictor of early post-
operative infection on both PODs 1 and 3. We could not
ﬁnd a correlation between SSI and the PCT concentration.
Silvestre et al. [2] recently described ﬁnding that in critically
ill surgical patients, an increase in PCT did not predict
complications.
Our results show that the surgical approach inﬂuences the
development of SSI and the mean values of inﬂammatory
markers are different statistically according to the approach
by laparoscopy or laparotomy. However, the clinical rele-
vance of these ﬁndings cannot be assessed from these data
because our study was not designed to evaluate the inﬂuence
of the surgical approach on SSI and inﬂammatory markers.
The study design did not assign patients to the laparotomy or
laparoscopy groups at baseline. Therefore, these groups are
not equally distributed, for example in terms of patients’ age,
and cannot be compared.
Finally, there are important limitations we shouldmake note
of. First, with an observational design and moderate sample
size, this study requires validation in large-scale prospective
multi-center trials. Second, because of the small sample, we
combined patients with organ/space SSIs with those with in-
cisional SSIs and analyzed them as one group. Although there
are signiﬁcant differences in CRP on POD1 and CRP and CAR
on POD3 in patients with and without SSI, further studies are
necessary to investigate the usefulness of those markers.
In conclusion, CRP on PO1 and CRP and CAR on POD3
can identify patients at low risk of SSI. Our study suggests
that they can be used as a prognostic tool to forecast an
uneventful post-operative period. They have been incorpo-
rate into our fast-track discharge criteria after elective colo-
rectal resection, improving clinical decision-making.
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